跳至主要内容
临床试验/EUCTR2012-003289-42-NL
EUCTR2012-003289-42-NL进行中(未招募)不适用

Randomized Controlled Trial Investigating the Efficacy and Safety of Nebulized Heparin versus Placebo in Burn Patients with Inhalation Trauma - Hepburn study

Academic Medical Center Amsterdam0 个研究点目标入组 118 人开始时间: 2012年12月21日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
118

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - informed consent
  • - age > 18 years
  • - need for invasive mechanical ventilation
  • - clinical diagnosis of inhalation trauma: initially on basis of indirect observations, followed by confirmation through bronchoscopy
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 85
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 33

排除标准

  • - > 36 hours after trauma
  • - Receiving invasive ventilation > 24 hours
  • - Expected duration of mechanical ventilation < 24 hours
  • - Chronic obstructive pulmonary disease GOLD stage III and IV
  • - Any history of pulmonary hemorrhage in the past 3 months
  • - Any history of significant bleeding disorder
  • - Known allergy to heparin, including heparin–induced thrombocytopenia
  • - Pregnancy or breast feeding
  • - Unlikely to survive for > 72 hours
  • - Total body surface area (TBSA) > 60%
  • - Witnessed or proven aspiration (i.e., confirmed by bronchoscopy)

研究者

发起方
Academic Medical Center Amsterdam

相似试验